The high prevalence of venous thromboembolism (VTE) in cancer patients, including catheter-related thrombosis (CRT), underscores the ongoing need to optimize clinical practice. The International Initiative on Thrombosis and Cancer-Continuing Medical Education (ITAC-CME) is committed to improving the lives and health outcomes of patients with solid tumors and hematologic malignancies, and to help reducing the substantial economic burden on healthcare systems associated with Cancer-associated thrombosis (CAT).
The International Initiative on Thrombosis and Cancer (ITAC), founded in 2013, is the international branch of the Groupe Francophone Thrombose et Cancer (GFTC), a French not for profit clinical research organization.
Our mission is accomplished through the dissemination of educational initiatives to physicians, nurses, and allied healthcare professionals worldwide, which are developed according to evidence-based clinical practice guidelines for the treatment and prophylaxis of VTE in cancer patients, including those published by ITAC. We have also produced a free interactive guideline app, which is currently available for iOS and Android, in five languages: English, French, Spanish, Portuguese and Russian.